Raidium key facts
as of Oct 2026- Developer of a radiology-augmented technology designed to tackle the complexity of precision medicine.
- Raidium is valued at approximately $55.6M as of Oct 2026 (last reported valuation).
- It has raised $18.2M; the latest was Seed Round ($1.2M) in Sep 2025.
- Notable investors include European Innovation Council, StartX (US), La French Tech, Founders Future, Newfund Management — 18 tracked in total.
- Status: Privately Held (backing).
Raidium's last reported valuation, Nov 2024. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Raidium: the Monday email on marks, rounds and moves
Raidium funding rounds
No funding rounds for Raidium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Raidium
18+Membership and data by Private Market View
Raidium valuation
Raidium's last reported valuation was $55.6 million in Nov 2024. No priced round, secondary trade or fund mark has surfaced since.
Raidium investors
18 investors are on record for Raidium, including European Innovation Council, StartX (US), La French Tech and Founders Future. By type, the record holds 5 venture capital firms.
About Raidium
Developer of a radiology-augmented technology designed to tackle the complexity of precision medicine. The company utilizes deep learning algorithms for the analysis of medical imaging data and develops a radiology console that brings artificial intelligence assistance directly to the radiologist's workflow via a diagnosis suggestion interface, enabling customers' access to imaging with a focus on screening, allowing earlier management of potential lethal diseases such as cancer, cardiovascular or metabolic pathologies.
- Sector
- Healthcare
- HQ
- Paris, France
- Employees
- 39
- Website
- raidium.eu/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.